About FDA
Total number of Public Inquiries by month (includes phone, email, and letter inquiries)
Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.
These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 6,534 |
| Nov 2011 | N/A | 5,281 |
| Dec 2011 | N/A | 5,590 |
| Jan 2012 | N/A | TBD |
| Feb 2012 | N/A | TBD |
| Mar 2012 | N/A | TBD |
| Apr 2012 | N/A | TBD |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 17,405
Number of phone inquires received in the month
Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 4,953 |
| Nov 2011 | N/A | 3,993 |
| Dec 2011 | N/A | 4,351 |
| Jan 2012 | N/A | TBD |
| Feb 2012 | N/A | TBD |
| Mar 2012 | N/A | TBD |
| Apr 2012 | N/A | TBD |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 13,297
Percent of phone calls with first contact resolution (i.e., phone call answered by FDA staff and response given; this statistic does not include phone calls received during non-business hours)
Fiscal Year - 2012
| Time | Target | Percent |
|---|---|---|
| Oct 2011 | N/A | 75 |
| Nov 2011 | N/A | 76 |
| Dec 2011 | N/A | 77 |
| Jan 2012 | N/A | TBD |
| Feb 2012 | N/A | TBD |
| Mar 2012 | N/A | TBD |
| Apr 2012 | N/A | TBD |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 3-month average: 76%
Number of email inquires received in the month
Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 1,471 |
| Nov 2011 | N/A | 1,269 |
| Dec 2011 | N/A | 1,146 |
| Jan 2012 | N/A | TBD |
| Feb 2012 | N/A | TBD |
| Mar 2012 | N/A | TBD |
| Apr 2012 | N/A | TBD |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 3,886
Number of letter correspondence received by CDER's Office of Communication in the month (30 day due date from time of receipt for a response by CDER's Office of Communications
Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 110 |
| Nov 2011 | N/A | 73 |
| Dec 2011 | N/A | 93 |
| Jan 2012 | N/A | TBD |
| Feb 2012 | N/A | TBD |
| Mar 2012 | N/A | TBD |
| Apr 2012 | N/A | TBD |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 276
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







